Ash Bullement
BSc, MSc
Population Health, School of Medicine and Population Health
PhD Student
Full contact details
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
91直播
S1 4DA
- Profile
-
I am a part-time PhD student at ScHARR, supervised by Dr Nick Latimer, Prof Matt Stevenson, and Prof Gianluca Baio (UCL). My research is focused on the use of external information to inform survival extrapolations based on clinical trials of cancer treatments. Outside of my PhD studies, I am a health economics analyst working in industry.
- Qualifications
-
BSc Mathematics, Statistics and Operational Research, Cardiff University
MSc Health Economics and Decision Modelling, University of 91直播
- Research interests
-
My research interests are on the use of survival analysis methodology to estimate survival curves for use in healthcare decision making, specifically health technology assessments of cancer treatments. I am especially interested in estimating longer-term survival for treatments with novel mechanistic properties that are associated with complex hazard functions.
The working title of my PhD is 鈥楢n exploration of methods to incorporate external information into survival modelling in oncology鈥.
- Publications
-
Show: Featured publications All publications
Featured publications
This person does not have any publications available.
All publications
Journal articles
- . BMC Cancer, 24(1).
- . Value in Health, 26(12), S120-S120.
- . Future Oncology, 19(9), 643-650.
- . Value in Health.
- . Value in Health, 25(1), S32-S33.
- . Journal of the Royal Statistical Society: Series A (Statistics in Society).
- . PharmacoEconomics.
- . Open Access Rheumatology: Research and Reviews, 13, 257-266.
- . PharmacoEconomics - Open.
- . Applied Health Economics and Health Policy.
- . Journal of Medical Economics, 23(10), 1176-1185.
- . International Journal of Technology Assessment in Health Care, 36(4), 388-394.
- . BMC Medical Research Methodology, 20.
- . PharmacoEconomics - Open, 4, 133-142.
- . Value in Health.
- . Applied Health Economics and Health Policy, 17(6), 771-780.
- . PharmacoEconomics, 37(11), 1383-1390.
- . Value in Health, 22, S479-S479.
- . Value in Health, 22, S456-S457.
- . Value in Health, 22, S456-S456.
- . PharmacoEconomics - Open, 3(3), 377-390.
- . Value in Health, 22, S105-S105.
- . Value in Health, 22, S44-S44.
- . Value in Health, 22, S389-S389.
- . Journal of Medical Economics, 22(3), 205-214.
- . Value in Health.
- . Annals of Oncology, 29, viii461-viii461.
- . PharmacoEconomics.
- . Clinical Colorectal Cancer, 17(1), e143-e151.
- . The Lancet, 391(10122), 748-757.
- . PharmacoEconomics, 34(11), 1145-1159.
- . PharmacoEconomics.
- . PharmacoEconomics.
- . Blood Advances.
- . Future Oncology.
- . PharmacoEconomics.
- . Medical Decision Making, 0272989X2311686-0272989X2311686.
- . Applied Health Economics and Health Policy.
- . PLOS ONE, 10(9), e0136207-e0136207.
- . PharmacoEconomics.
- Incorporating external trial data to improve survival extrapolations: a pilot study of the COU-AA-301 trial. Health Services and Outcomes Research Methodology.
Conference proceedings papers
- . Value in Health, Vol. 23 (pp S539-S539), 16 November 2020 - 19 November 2020.
- . Value in Health, Vol. 22 (pp S577-S578)
- . Value in Health, Vol. 21 (pp S379-S379)
- . Value in Health, Vol. 21 (pp S378-S379)
- . Value in Health, Vol. 21 (pp S11-S11)
- . Value in Health, Vol. 21 (pp S465-S465)
- . Value in Health, Vol. 21 (pp S8-S8)
- . Journal of Clinical Oncology, Vol. 36(15_suppl) (pp e21620-e21620)
- . Value in Health, Vol. 20(9) (pp A746-A746)
- . Value in Health, Vol. 20(9) (pp A440-A440)
- . Value in Health, Vol. 20(9) (pp A422-A422)
- . Value in Health, Vol. 19(7) (pp A378-A379)
- . Value in Health, Vol. 17(3) (pp A61-A61)